About 3 results found for searched term "GAPDH-IN-1" (0.118 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M42944 | hGAPDH-IN-1 | Others |
| hGAPDH-IN-1, a 3-bromo-4,5-dihydroisoxazole derivative, is a specific and potent hGAPDH covalent inhibitor. | ||
| M58662 | GAPDH-IN-1 | Others |
| GAPDH Inhibitor Compound F8 | ||
| GAPDH-IN-1 (GAPDH Inhibitor Compound F8) is a covalent inhibitor of GAPDH (IC50 = 39.31 µM). It viability of, and glucose metabolism in, HEK293 cells in a concentration-dependent manner. | ||
| M29097 | Omigapil maleate | Apoptosis |
| CGP3466B; CGP3446 maleate; TCH346 maleate | ||
| Omigapil maleate, an orally bioavailable GAPDH nitrosylation inhibitor, abrogates Aβ1-42-induced tau acetylation, memory impairment, and locomotor dysfunction in mice. Omigapil maleate has the potential for the research of Alzheimer's disease. Omigapil maleate (CGP3446B maleate) is a apoptosis inhibitor. Omigapil maleate can be used for the research of congenital muscular dystrophy (CMD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
